PT-141 10mg

Description

A synthetic melanocortin receptor agonist studied for its role in central nervous system signaling and neurogenic pathways.

PT-141, also known as Bremelanotide, is a synthetic peptide analogue of the naturally occurring melanocortin peptide hormone α-melanocyte-stimulating hormone (α-MSH). It is a cyclic heptapeptide lactam that functions as a non-selective agonist of the melanocortin receptors, primarily targeting MC3R and MC4R. Originally derived from the peptide Melanotan II, PT-141 was developed through research focusing on the internal mechanisms of the central nervous system rather than direct vascular action. In laboratory settings, PT-141 is extensively studied for its unique interaction with the hypothalamus. Unlike other compounds that act on the cardiovascular system, research suggests that Bremelanotide exerts its influence via the activation of melanocortin pathways in the brain. This biochemical pathway has made PT-141 a primary subject of investigation regarding its role in neurogenic signaling and various physiological responses regulated by the central nervous system.

Product Overview

PT-141 (Bremelanotide) is a research-grade synthetic peptide. It is a truncated analogue of alpha-MSH and belongs to the melanocortin class of compounds. This product is provided as a highly purified lyophilised powder, intended strictly for laboratory research and in vitro experimentation. Research indicates that the compound possesses a high affinity for MC3 and MC4 receptors, distinguishing it from traditional research chemicals that target systemic blood flow.

Specifications

Chemical Name: Bremelanotide acetate Form: Lyophilised white powder Molecular Formula: C50H68N14O10 Quantity: 10mg Purity: ≥99% (HPLC verified) Storage: Store in a cool, dry place, away from direct light. For long-term stability, keep refrigerated.

Research Applications

Current scientific literature focuses on PT-141’s potential in modulating sexual dysfunction and libido-related pathways in animal models. Because it acts on the central nervous system rather than the vascular system, researchers utilize this peptide to study the neural mechanisms of arousal and the activation of dopamine-rich neurons in the medial preoptic area. Additionally, it is studied for its potential effects on inflammation and ischaemia-reperfusion injury due to its broader melanocortin receptor activity.

Research Use Notice

For laboratory research use only. Not for human or veterinary use.